Cargando…

The “discordant doppelganger dilemma”: SGLT2i mimics therapeutic carbohydrate restriction - food choice first over pharma?

Detalles Bibliográficos
Autores principales:	Murray, Scott W., McKelvey, Sean, Heseltine, Thomas D., Henderson, George, Singh, Jagdeep, Unwin, David, Brady, Adrian J. B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8373610/ https://www.ncbi.nlm.nih.gov/pubmed/33564065 http://dx.doi.org/10.1038/s41371-021-00482-y

Ejemplares similares

Doppelgänger dilemma: Leiomyoma versus uveal melanoma
por: Tomar, Ankit Singh, et al.
Publicado: (2021)

Protocol to identify functional doppelgängers and verify biomedical gene expression data using doppelgangerIdentifier
por: Wang, Li Rong, et al.
Publicado: (2022)

The doppelganger tooth: A diagnostic conundrum!
por: Dhawan, Preeti, et al.
Publicado: (2015)

Doppelgänger spotting in biomedical gene expression data
por: Wang, Li Rong, et al.
Publicado: (2022)

The Dat Project, an open and decentralized research data tool
por: Robinson, Danielle C., et al.
Publicado: (2018)

A Widow-Maker and a Doppelganger: An Anomalous Case of the Coronaries
por: Malik, Jahanzeb, et al.
Publicado: (2020)

SGLT2 inhibitors and renal complications in type 1 diabetes
por: Petrie, John R
Publicado: (2020)

Siblings or doppelgängers? Deciphering the evolution of structured cis-regulatory RNAs beyond homology
por: Gray, Elizabeth C., et al.
Publicado: (2020)

From choice architecture to choice engineering
por: Dan, Ohad, et al.
Publicado: (2019)

The Image of Pharma
Publicado: (2007)

Pharma-Ecology
por: Jjemba, Patrick
Publicado: (2018)

Salty ice and the dilemma of ocean exoplanet habitability
por: Journaux, Baptiste
Publicado: (2022)

Does SARS-CoV-2vaccination induce acquired autoimmune discords and inflammatory manifestations?
por: Bahrini, Khadija, et al.
Publicado: (2023)

COVID-19 highlights the model dilemma in biomedical research
por: Adhikary, Partho Protim, et al.
Publicado: (2021)

Doppelganger-based training: Imitating our virtual self to accelerate interpersonal skills learning
por: Kleinlogel, Emmanuelle P., et al.
Publicado: (2021)

Limited choice of natural amino acids as mimetics restricts design of protein lysine methylation studies
por: Weirich, Sara, et al.
Publicado: (2023)

Lack of durable natriuresis and objective decongestion following SGLT2 inhibition in randomized controlled trials of patients with heart failure
por: Packer, Milton
Publicado: (2023)

Big Pharma (The Play)
por: Bero, Lisa
Publicado: (2007)

Deciding priorities in Pharma
por: Koehler, Maria
Publicado: (2010)

Do low-carbohydrate diets increase energy expenditure?
por: Hall, Kevin D., et al.
Publicado: (2019)

Trained innate immunity, COVID-19 therapeutic dilemma, and fake science
por: Belizário, José Ernesto
Publicado: (2020)

The Doppelgänger phenomenon and death: a peculiar case of homicide by a subject with first-episode psychosis
por: Barbieri, Cristiano, et al.
Publicado: (2022)

A randomized controlled trial of pharmacist-led therapeutic carbohydrate and energy restriction in type 2 diabetes
por: Durrer, Cody, et al.
Publicado: (2021)

To best mimic human thermal conditions, mice should be housed slightly below thermoneutrality
por: Keijer, Jaap, et al.
Publicado: (2019)

Many-qubit protection-operation dilemma from the perspective of many-body localization
por: Silveri, Matti, et al.
Publicado: (2022)

Recent UK type 2 diabetes treatment guidance represents a near whole population indication for SGLT2-inhibitor therapy
por: Young, Katherine G., et al.
Publicado: (2023)

EMPA-KIDNEY: expanding the range of kidney protection by SGLT2 inhibitors
por: Fernández-Fernandez, Beatriz, et al.
Publicado: (2023)

Influenza vaccination and interruption of methotrexate in adult patients in the COVID-19 era: an ongoing dilemma
por: Mehta, Puja, et al.
Publicado: (2021)

Paucity and discordance of neutralising antibody responses to SARS-CoV-2 VOCs in vaccinated immunodeficient patients and health-care workers in the UK
por: Nadesalingam, Angalee, et al.
Publicado: (2021)

Risk, responsibility, and choice in research ethics
por: Cook, Elizabeth, et al.
Publicado: (2022)

Author Correction: A randomized controlled trial of pharmacist-led therapeutic carbohydrate and energy restriction in type 2 diabetes
por: Durrer, Cody, et al.
Publicado: (2022)

Pharmacist-led therapeutic carbohydrate restriction as a treatment strategy for type 2 diabetes: the Pharm-TCR randomized controlled trial protocol
por: Durrer, Cody, et al.
Publicado: (2019)

Pathologic Doppelgänger: Thyroid–like intrahepatic cholangiocarcinoma with synchronous primary thyroid carcinoma in a young woman
por: Mittal, Neha, et al.
Publicado: (2020)

Invisible doppelgänger and body image disorders in right superior parietal lobule stroke, a case series
por: Kumral, Emre, et al.
Publicado: (2022)

Land, lava, and disaster create a social dilemma after the 2018 eruption of Kīlauea volcano
por: Houghton, Bruce F., et al.
Publicado: (2021)

Are the Cardiorenal Benefits of SGLT2 Inhibitors Due to Inhibition of the Sympathetic Nervous System?
por: Verma, Subodh
Publicado: (2020)

Empagliflozin and Protecting Microvascular Support of Heart Mechanics: SGLT2 Inhibition or More?
por: Mantsounga, Chris Sorel, et al.
Publicado: (2019)

Global Pharma: Managing Uncertainty
por: Munson, Chuck
Publicado: (2013)

What Propels The Pharma Industry?
Publicado: (2007)

An open source pharma roadmap
por: Balasegaram, Manica, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_hn4ai6tere4vbs1b1q5cbh42bl